AYTU BIOPHARMA, INC Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-08-15: Form PRE 14A; Period of report 2022-10-05; Description PRE 14A; Document tmb-20221005xpre14a.htm.
- 2020-02-21: Form PRE 14A; Period of report 2020-02-21; Description PRELIMINARY PROXY STATEMENT; Document pre14a0220_aytubioscienceinc.htm.
- 2019-11-04: Form PRE 14A; Period of report 2019-12-13; Description PRELIMINARY PROXY STATEMENT; Document aytu_pre14a.htm.
- 2019-02-14: Form PRE 14A; Period of report 2019-04-12; Description PRE 14A; Document aytu_pre14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-08-15 | PRE 14A | 2022-10-05 | PRE 14A | tmb-20221005xpre14a.htm |
| 2020-02-21 | PRE 14A | 2020-02-21 | PRELIMINARY PROXY STATEMENT | pre14a0220_aytubioscienceinc.htm |
| 2019-11-04 | PRE 14A | 2019-12-13 | PRELIMINARY PROXY STATEMENT | aytu_pre14a.htm |
| 2019-02-14 | PRE 14A | 2019-04-12 | PRE 14A | aytu_pre14a.htm |
| 2018-04-27 | PRE 14A | 2018-06-27 | PRELIMINARY PROXY STATEMENT | pre14a0418_aytubioscience.htm |
| 2017-05-25 | PRE 14A | 2017-05-25 | PRE 14A | v467735_pre14a.htm |
| 2016-09-13 | PRE 14A | 2016-09-13 | PRE 14A | v448707_pre14a.htm |
| 2016-03-15 | PRE 14A | 2016-03-15 | PRE 14A | v434267_pre14a.htm |
| 2015-04-27 | PRE 14A | 2015-05-04 | PRE 14A | d910772dpre14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |